Brief: First Wave Biopharma Chairman And CEO Issues Letter To Stockholders

GridAI Technologies

05/07/2023 12:09

July 5 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA CHAIRMAN AND CEO ISSUES LETTER TO
STOCKHOLDERS
    * FIRST WAVE BIOPHARMA INC - PHASE 2 SPAN TRIAL TOPLINE DATA
EXPECTED IN JULY
    * FIRST WAVE BIOPHARMA INC - IP PROTECTION FOR ADRULIPASE
EXTENDS
INTO 2042-2043 TIMEFRAME
    * FIRST WAVE BIOPHARMA INC -  AIM TO SECURE SCHEDULING END
OF
PHASE 2 MEETING WITH U.S. FDA FOR ADRULIPASE IN Q4 OF 2023

Source text for Eikon:  ID:nGNX54BNhs 
Further company coverage:  FWBI.O 

 (Reuters.Briefs@thomsonreuters.com)